Derleme
BibTex RIS Kaynak Göster

Pürülan Enfeksiyöz Miyozit

Yıl 2023, Cilt: 6 Sayı: 1, 185 - 188, 01.01.2023
https://doi.org/10.19127/bshealthscience.1164897

Öz

Pürülan enfeksiyöz miyozit; deri ve yumuşak doku enfeksiyonları sınıfındadır ve eskiden sadece tropikal bölgelerden bildirilmiş olduğundan tropikal miyozit olarak tanımlanan bir hastalıktır. Daha önceleri olguların genç erkeklerde gelişen bir hastalık olduğu düşünülmekteydi ancak hastalığa dair farkındalığın artması ile farklı teoriler ortaya çıkmış ve dünya genelinden ve tüm yaş gruplarından (çocuklar ve yaşlılar dahil) olgular bildirilmiştir. Bu hastalık çizgili kasların inflamasyonudur. Primer veya sekonder olarak gelişebilir. En sık etkeni cilt flora üyesi olan Staphylococcus aureus olmakla birlikte immunsupresif olgularda veya sekonder olgularda çok farklı etkenlerin bu hastalığa sebep olduğu bildirilmiştir. Bu derleme çalışmasında, pürülan enfeksiyöz miyozite neden olan çeşitli patojenler, tanı ve tedavi yöntemleri tartışılmaktadır.

Destekleyen Kurum

yok

Proje Numarası

yok

Kaynakça

  • Al-Najar M, Obeidat F, Ajlouni J, Mithqal A, Hadidy A. 2010. Primary extensive pyomyositis in an immunocompetent patient: case report and literature review. Clin Rheumatol, 29(12): 1469-1472.
  • Ak Ö, Diktaş H, Şenbayrak S, Saltoğlu N. 2020. Deri ve yumuşak doku infeksiyonları: Tanı ve tedavi. Klimik J, 33(3): 200-212.
  • Bickels J, Ben-Sira L, Kessler A, Wientroub S. 2002. Primary pyomyositis. The Journal of bone and joint surgery. American Vol, 84(12): 2277-2286. DOI: 10.2106/00004623-200212000-00024.
  • Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. 2008. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediat Radiol, 38(8): 841-847. DOI: 10.1007/s00247-008-0888-8.
  • Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP. 2004. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol, 42(9): 4050-4053. DOI: 10.1128/JCM.42.9.4050-4053.2004.
  • Cooke NM, Smith SG, Kelleher M, Rogers TR. 2010. Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol, 48(4): 1099-1104.
  • Crum NF. 2004. Bacterial pyomyositis in the United States. American J Medic, 117(6): 420-428. DOI: 10.1016/j.amjmed.2004.03.031.
  • Elzohairy MM. 2018. Primary pyomyositis in children. Orthop Traumatol Surg Res, 104(3): 397-403. DOI: 10.1016/j.otsr.2017.12.005.
  • Engel D. 1981. Tropical pyomyositis, a thiaminedeficiency disease. Medic Hypoth, 7(3): 345-352.
  • Evans JA, Ewald MB. 2005. Pyomyositis: a fatal case in a healthy teenager. Pediat Emerg Care, 21(6): 375-377. DOI: 10.1097/01.pec.0000166728.86094.c9.
  • Foster WD. 1965. The bacteriology of tropical pyomyositis in Uganda. J Hygiene, 63(4): 517-524. DOI: 10.1017/s002217240004540x.
  • Habeych ME, Trinh T, Crum-Cianflone NF. 2020. Purulent infectious myositis (formerly tropical pyomyositis). J Neurol Sci, 413: 116767. DOI: 10.1016/j.jns.2020.116767.
  • Hajjaji N, Cattier B, Lanotte P, Legras A, Perrotin D. 2004. Mycobacterium chelonae myositis. Presse Medic, 33(21): 1519-1520. DOI: 10.1016/s0755-4982(04)98976-2.
  • Hossain A, Reis ED, Soundararajan K, Kerstein MD, Hollier LH. 2000. Nontropical pyomyositis: analysis of eight patients in an urban center. American Surg, 66(11): 1064-1066.
  • Jayoussi R, Bialik V, Eyal A, Shehadeh N, Etzioni A. 1995. Pyomyositis caused by vigorous exercise in a boy. Acta Paediatrica, 84(2): 226-227. DOI: 10.1111/j.1651-2227.1995.tb13618.x.
  • Jenkins V, Steinke J, Rajendran N, Kumar D. 2018. Purulent myositis of the thigh as a presentation of perforated low rectal cancer. Annals Royal Coll Surg England, 100(3): e44-e45. DOI: 10.1308/rcsann.2017.0210.
  • King RJ, Laugharne D, Kerslake RW, Holdsworth BJ. 2003. Primary obturator pyomyositis: a diagnostic challenge. J Bone Joint Surg, 85(6): 895-898.
  • Levin MJ, Gardner P, Waldvogel FA. 1971. Tropical pyomyositis: an unusual infection due to Staphylococcus aureus. New England J Medic, 284(4): 196-198
  • Lin MY, Rezai K, Schwartz DN. 2008. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol, 46(4): 1553-1555. DOI: 10.1128/JCM.02379-07.
  • Low DE, Norrby-Teglund N. 2012. Myositis, pyomyositis, and necrotizing fasciitis. In: SS Long, LK Pickering, CG sProber, eds. Principles and Practice of Pediatric Infectious Diseases. 4th ed, Elsevier Saunders, Edinburgh, UK, pp: 462-468.
  • Minami K, Kenzaka T, Kumabe A, Matsumura M. 2017. Thigh pyomyositis caused by group A streptococcus in an immunocompetent adult without any cause. BMC Res Not, 10(1): 33. DOI: 10.1186/s13104-016-2346-2.
  • Mohan S, Meena MK, Kant R. 2020. Purulent Infectious Myositis: Its Anguish and Ubiquitous!. American J Infect Diseas, 16(4): 131-134. DOI: 10.3844/ajidsp.2020.131.134.
  • Molina B, Pogossian A, De Moreuil C, Rouvière B, Le Berre R. 2020. Infectious myositis. La Revue de Medec Int, 41(4): 241-249. DOI: 10.1016/j.revmed.2020.02.006.
  • Narayanappa G, Nandeesh BN. 2021. Infective myositis. Brain Pathol, 31(3): e12950. DOI: 10.1111/bpa.12950.
  • Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO, Kaplan SL. 2006. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Diseas, 43(8): 953-960. DOI: 10.1086/507637.
  • Romeo S, Sunshine S. 2000. Pyomyositis in a 5-year-old child. Arch Family Medic, 9(7): 653-656.
  • Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microb Infect, 5(5): 449-456.
  • Seok JH, Jee WH, Chun KA, Kim JY, Jung CK, Kim YR, Eo WK, Kim YS, Chung YG. 2009. Necrotizing fasciitis versus pyomyositis: discrimination with using MR imaging. Korean J Radiol, 10(2): 121-128. DOI: 10.3348/kjr.2009.10.2.121.
  • Sharma A, Kumar S, Wanchu A, Sharma K, Sharma N, Singh R, Bambery P, Singh S, Varma S. 2010. Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol, 29(1): 45-51. DOI: 10.1007/s10067-009-1277-x.
  • Scriba J. 1885. Beitrag zur aetiologie der myositis acuta. Dtsch Z Chir, 22: 497-502.
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Infectious Diseases Society of America. 2014. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Diseas, 59(2): e10-e52. DOI: 10.1093/cid/ciu444.
  • Taksande A, Vilhekar K, Gupta S. 2009. Primary pyomyositis in a child. International journal of infectious diseases: Int Soc Infect Diseas, 13(4): e149-e151. DOI: 10.1016/j.ijid.2008.08.013.
  • Theodorou SJ, Theodorou DJ, Resnick D. 2007. MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases. Emerg Radiol, 14(2): 89-96. DOI: 10.1007/s10140-007-0593-1.
  • Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Adachi JA. 2010. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Diseas, 50(3): 374-380.

Purulent Infectious Myositis

Yıl 2023, Cilt: 6 Sayı: 1, 185 - 188, 01.01.2023
https://doi.org/10.19127/bshealthscience.1164897

Öz

Purulent infectious myositis, which is classified as skin and soft tissue infections, was a disease defined as tropical myositis since it was previously reported only from tropical regions. In addition, it was previously thought that the cases were a disease that developed in young men. However, with the increasing awareness of the disease, different theories have emerged and cases have been reported worldwide and from all age groups (including children and the elderly). This disease is inflammation of striated muscles. It can develop as primary or secondary. The most common causative agent is Staphylococcus aureus, a member of the skin flora, and it has been reported that many different factors cause this disease in immunosuppressive or secondary cases. In this review study, various pathogens causing purulent infectious myositis, diagnosis and treatment methods are discussed.

Proje Numarası

yok

Kaynakça

  • Al-Najar M, Obeidat F, Ajlouni J, Mithqal A, Hadidy A. 2010. Primary extensive pyomyositis in an immunocompetent patient: case report and literature review. Clin Rheumatol, 29(12): 1469-1472.
  • Ak Ö, Diktaş H, Şenbayrak S, Saltoğlu N. 2020. Deri ve yumuşak doku infeksiyonları: Tanı ve tedavi. Klimik J, 33(3): 200-212.
  • Bickels J, Ben-Sira L, Kessler A, Wientroub S. 2002. Primary pyomyositis. The Journal of bone and joint surgery. American Vol, 84(12): 2277-2286. DOI: 10.2106/00004623-200212000-00024.
  • Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. 2008. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediat Radiol, 38(8): 841-847. DOI: 10.1007/s00247-008-0888-8.
  • Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP. 2004. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol, 42(9): 4050-4053. DOI: 10.1128/JCM.42.9.4050-4053.2004.
  • Cooke NM, Smith SG, Kelleher M, Rogers TR. 2010. Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol, 48(4): 1099-1104.
  • Crum NF. 2004. Bacterial pyomyositis in the United States. American J Medic, 117(6): 420-428. DOI: 10.1016/j.amjmed.2004.03.031.
  • Elzohairy MM. 2018. Primary pyomyositis in children. Orthop Traumatol Surg Res, 104(3): 397-403. DOI: 10.1016/j.otsr.2017.12.005.
  • Engel D. 1981. Tropical pyomyositis, a thiaminedeficiency disease. Medic Hypoth, 7(3): 345-352.
  • Evans JA, Ewald MB. 2005. Pyomyositis: a fatal case in a healthy teenager. Pediat Emerg Care, 21(6): 375-377. DOI: 10.1097/01.pec.0000166728.86094.c9.
  • Foster WD. 1965. The bacteriology of tropical pyomyositis in Uganda. J Hygiene, 63(4): 517-524. DOI: 10.1017/s002217240004540x.
  • Habeych ME, Trinh T, Crum-Cianflone NF. 2020. Purulent infectious myositis (formerly tropical pyomyositis). J Neurol Sci, 413: 116767. DOI: 10.1016/j.jns.2020.116767.
  • Hajjaji N, Cattier B, Lanotte P, Legras A, Perrotin D. 2004. Mycobacterium chelonae myositis. Presse Medic, 33(21): 1519-1520. DOI: 10.1016/s0755-4982(04)98976-2.
  • Hossain A, Reis ED, Soundararajan K, Kerstein MD, Hollier LH. 2000. Nontropical pyomyositis: analysis of eight patients in an urban center. American Surg, 66(11): 1064-1066.
  • Jayoussi R, Bialik V, Eyal A, Shehadeh N, Etzioni A. 1995. Pyomyositis caused by vigorous exercise in a boy. Acta Paediatrica, 84(2): 226-227. DOI: 10.1111/j.1651-2227.1995.tb13618.x.
  • Jenkins V, Steinke J, Rajendran N, Kumar D. 2018. Purulent myositis of the thigh as a presentation of perforated low rectal cancer. Annals Royal Coll Surg England, 100(3): e44-e45. DOI: 10.1308/rcsann.2017.0210.
  • King RJ, Laugharne D, Kerslake RW, Holdsworth BJ. 2003. Primary obturator pyomyositis: a diagnostic challenge. J Bone Joint Surg, 85(6): 895-898.
  • Levin MJ, Gardner P, Waldvogel FA. 1971. Tropical pyomyositis: an unusual infection due to Staphylococcus aureus. New England J Medic, 284(4): 196-198
  • Lin MY, Rezai K, Schwartz DN. 2008. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol, 46(4): 1553-1555. DOI: 10.1128/JCM.02379-07.
  • Low DE, Norrby-Teglund N. 2012. Myositis, pyomyositis, and necrotizing fasciitis. In: SS Long, LK Pickering, CG sProber, eds. Principles and Practice of Pediatric Infectious Diseases. 4th ed, Elsevier Saunders, Edinburgh, UK, pp: 462-468.
  • Minami K, Kenzaka T, Kumabe A, Matsumura M. 2017. Thigh pyomyositis caused by group A streptococcus in an immunocompetent adult without any cause. BMC Res Not, 10(1): 33. DOI: 10.1186/s13104-016-2346-2.
  • Mohan S, Meena MK, Kant R. 2020. Purulent Infectious Myositis: Its Anguish and Ubiquitous!. American J Infect Diseas, 16(4): 131-134. DOI: 10.3844/ajidsp.2020.131.134.
  • Molina B, Pogossian A, De Moreuil C, Rouvière B, Le Berre R. 2020. Infectious myositis. La Revue de Medec Int, 41(4): 241-249. DOI: 10.1016/j.revmed.2020.02.006.
  • Narayanappa G, Nandeesh BN. 2021. Infective myositis. Brain Pathol, 31(3): e12950. DOI: 10.1111/bpa.12950.
  • Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO, Kaplan SL. 2006. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Diseas, 43(8): 953-960. DOI: 10.1086/507637.
  • Romeo S, Sunshine S. 2000. Pyomyositis in a 5-year-old child. Arch Family Medic, 9(7): 653-656.
  • Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microb Infect, 5(5): 449-456.
  • Seok JH, Jee WH, Chun KA, Kim JY, Jung CK, Kim YR, Eo WK, Kim YS, Chung YG. 2009. Necrotizing fasciitis versus pyomyositis: discrimination with using MR imaging. Korean J Radiol, 10(2): 121-128. DOI: 10.3348/kjr.2009.10.2.121.
  • Sharma A, Kumar S, Wanchu A, Sharma K, Sharma N, Singh R, Bambery P, Singh S, Varma S. 2010. Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol, 29(1): 45-51. DOI: 10.1007/s10067-009-1277-x.
  • Scriba J. 1885. Beitrag zur aetiologie der myositis acuta. Dtsch Z Chir, 22: 497-502.
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Infectious Diseases Society of America. 2014. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Diseas, 59(2): e10-e52. DOI: 10.1093/cid/ciu444.
  • Taksande A, Vilhekar K, Gupta S. 2009. Primary pyomyositis in a child. International journal of infectious diseases: Int Soc Infect Diseas, 13(4): e149-e151. DOI: 10.1016/j.ijid.2008.08.013.
  • Theodorou SJ, Theodorou DJ, Resnick D. 2007. MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases. Emerg Radiol, 14(2): 89-96. DOI: 10.1007/s10140-007-0593-1.
  • Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Adachi JA. 2010. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Diseas, 50(3): 374-380.
Toplam 34 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Klinik Tıp Bilimleri
Bölüm Derleme
Yazarlar

Mustafa Serhat Şahinoğlu 0000-0001-9036-0269

Sevil Alkan 0000-0003-1944-2477

Proje Numarası yok
Yayımlanma Tarihi 1 Ocak 2023
Gönderilme Tarihi 22 Ağustos 2022
Kabul Tarihi 25 Eylül 2022
Yayımlandığı Sayı Yıl 2023 Cilt: 6 Sayı: 1

Kaynak Göster

APA Şahinoğlu, M. S., & Alkan, S. (2023). Pürülan Enfeksiyöz Miyozit. Black Sea Journal of Health Science, 6(1), 185-188. https://doi.org/10.19127/bshealthscience.1164897
AMA Şahinoğlu MS, Alkan S. Pürülan Enfeksiyöz Miyozit. BSJ Health Sci. Ocak 2023;6(1):185-188. doi:10.19127/bshealthscience.1164897
Chicago Şahinoğlu, Mustafa Serhat, ve Sevil Alkan. “Pürülan Enfeksiyöz Miyozit”. Black Sea Journal of Health Science 6, sy. 1 (Ocak 2023): 185-88. https://doi.org/10.19127/bshealthscience.1164897.
EndNote Şahinoğlu MS, Alkan S (01 Ocak 2023) Pürülan Enfeksiyöz Miyozit. Black Sea Journal of Health Science 6 1 185–188.
IEEE M. S. Şahinoğlu ve S. Alkan, “Pürülan Enfeksiyöz Miyozit”, BSJ Health Sci., c. 6, sy. 1, ss. 185–188, 2023, doi: 10.19127/bshealthscience.1164897.
ISNAD Şahinoğlu, Mustafa Serhat - Alkan, Sevil. “Pürülan Enfeksiyöz Miyozit”. Black Sea Journal of Health Science 6/1 (Ocak 2023), 185-188. https://doi.org/10.19127/bshealthscience.1164897.
JAMA Şahinoğlu MS, Alkan S. Pürülan Enfeksiyöz Miyozit. BSJ Health Sci. 2023;6:185–188.
MLA Şahinoğlu, Mustafa Serhat ve Sevil Alkan. “Pürülan Enfeksiyöz Miyozit”. Black Sea Journal of Health Science, c. 6, sy. 1, 2023, ss. 185-8, doi:10.19127/bshealthscience.1164897.
Vancouver Şahinoğlu MS, Alkan S. Pürülan Enfeksiyöz Miyozit. BSJ Health Sci. 2023;6(1):185-8.